Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,945,290
+$471,069 QoQ
Shares Held
11,597
+14.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#2,019
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Shepherd Financial Partners LLC holds $27,627,511 across 8 Drug Manufacturers - General names. JNJ ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,583 | $11,494,138 | |
| 2 | ABBV |
AbbVie Inc.
|
25,552 | $6,429,905 | |
| 3 | MRK |
Merck & Co., Inc.
|
32,703 | $4,202,335 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
11,597 | $2,945,290 | |
| 5 | AMGN |
Amgen Inc
|
4,462 | $1,615,779 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,173 | $400,876 | |
| 7 | PFE |
Pfizer Inc
|
13,337 | $321,154 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,784 | $218,034 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,945,290 | 11,597 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,474,221 | 10,122 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,137,793 | 10,330 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,935,043 | 10,436 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,663,905 | 10,893 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,776,809 | 10,714 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $1,555,532 | 10,756 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,797,407 | 11,091 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,596,944 | 10,926 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,813,648 | 11,465 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,794,359 | 11,448 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,747,203 | 11,218 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,750,042 | 10,573 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,602,235 | 10,337 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,795,823 | 10,166 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,626,738 | 9,958 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,280,293 | 12,846 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,856,307 | 10,474 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,283,196 | 7,501 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $967,223 | 5,989 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $968,176 | 5,877 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $967,199 | 5,885 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,742,983 | 11,075 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,613,412 | 10,837 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,559,164 | 11,087 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,425,251 | 10,869 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||